Prostate Cancer Subclinical Metastatic Ablative MR-guided Radiotherapy
Phase II Study: [18F]DCFPyL PET/MRI for Personalizing Prostate Cancer Subclinical Metastatic Ablative MR-guided Radiotherapy (MRgRT)
Sponsor: University Health Network, Toronto
This NA trial investigates Post Prostatectomy and is currently actively recruiting participants. University Health Network, Toronto leads this study, which shows 14 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
14 versions recorded-
Mar 2025 — Present [monthly]
Recruiting NA
-
Sep 2024 — Mar 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Jan 2024 — Jul 2024 [monthly]
Recruiting NA
-
Jun 2023 — Jan 2024 [monthly]
Recruiting NA
▶ Show 9 earlier versions
-
Jan 2022 — Jun 2023 [monthly]
Recruiting NA
-
Nov 2021 — Jan 2022 [monthly]
Recruiting NA
-
May 2021 — Nov 2021 [monthly]
Recruiting NA
Phase: PHASE2 → NA
-
Jan 2021 — May 2021 [monthly]
Recruiting PHASE2
-
Jan 2020 — Jan 2021 [monthly]
Recruiting PHASE2
-
Dec 2019 — Jan 2020 [monthly]
Recruiting PHASE2
-
Oct 2018 — Dec 2019 [monthly]
Recruiting PHASE2
-
Jun 2018 — Oct 2018 [monthly]
Recruiting PHASE2
-
Jun 2017 — Jun 2018 [monthly]
Recruiting PHASE2
First recorded
May 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Health Network, Toronto
For direct contact, visit the study record on ClinicalTrials.gov .